Search for: "GENENTECH, INC."
Results 321 - 340
of 469
Sorted by Relevance
|
Sort by Date
6 Jun 2012, 5:19 pm
Genentech, Inc., 549 U.S. 118 (2007). [read post]
15 Jun 2011, 4:56 am
Sun Pharma Global FZE (Patent Docs) Valcyte (Valganciclovir) – US: patent infringement complaint filed in response to Para IV certification: Genentech, Inc. et al. v. [read post]
27 Jan 2016, 8:12 am
Genentech, Inc., 2012 WL 956192 (S.D. [read post]
31 Jan 2017, 5:48 pm
Genentech, Inc., 76 U. [read post]
31 May 2012, 11:42 am
Prometheus Laboratories, Inc., 132 S. [read post]
14 Oct 2014, 12:59 pm
See, e.g., Genentech, Inc. v. [read post]
2 Aug 2015, 4:01 pm
| Pro-Football Inc v Amanda Blackhorse et al. [read post]
21 Nov 2010, 5:56 pm
Genentech, Inc., No. 4:10CV1793-JCH (E.D. [read post]
19 Jan 2017, 4:50 pm
While refusing to license Phigenix’s patent, Genentech licensed a patent from ImmunoGen, Inc., for use in making Kadcyla. [read post]
16 Apr 2012, 4:04 am
Genentech, Inc., 549 U.S. 118 (2007), Cardinal Chem. [read post]
1 Jun 2007, 6:45 am
Genentech, Inc., the Court made it easier for a patent licensee to challenge the validity of the patent being licensed. [read post]
6 Oct 2010, 4:22 am
Sandoz, Inc. et al (Docket Report) [read post]
28 Mar 2009, 4:40 pm
., Craig Allen Nard, The Law of Patents 34 (2008) (asserting PTO grants patents on 39% of applications); Brief of the Boston Patent Law Ass'n as Amicus Curiae in Support of Genentech, Inc., on the Merits at 5, Medimmune, Inc. v. [read post]
28 Nov 2012, 6:04 pm
On October 31st, 2012, Myriad Genetics, Inc. et al. responded and filed its brief in opposition to Supreme Court review (see our post of November 14, 2012). [read post]
20 Aug 2010, 5:46 pm
Genentech, Inc. v. [read post]
6 Aug 2013, 8:36 am
See Southwall Tech., Inc. v. [read post]
14 Dec 2021, 9:57 am
Genentech, Inc., 549 U.S. 118 (2007) where the Supreme Court found standing for a licensee to challenge a patent. [read post]
24 Feb 2022, 6:12 pm
Genentech, Inc., 549 U.S. 118 (2007) where the Supreme Court found standing for a licensee to challenge a patent — and rejecting the Federal Circuit’s reasonable-apprehension-of-suit requirement. [read post]
20 Dec 2023, 5:00 am
Monoclonal Antibodies Inc., 1985) protected large genus claims. [read post]
1 Dec 2010, 7:32 am
Cir. 2009) (rejecting a plaintiff's litigation-inspired attempts to create contacts in the jurisdiction for purposes of manipulating venue); In re Genentech, Inc., 566 F.3d 1338 (Fed. [read post]
